Top

Published in:

01-12-2018 | Editorial

Iron deficiency and infection: another pathway to explore in critically ill patients?

Authors: Erik R. Swenson, Raphaël Porcher, Michaël Piagnerelli

Published in: Intensive Care Medicine | Issue 12/2018

Excerpt

Anaemia is a common pathology with a high prevalence and incidence in the general population worldwide and one of the leading causes of years lived with disability and of mortality in myriad chronic medical illnesses [1]. Aetiologies are different depending especially on age and geographical location. In a systematic analysis for the Global Burden of Disease, Kassenbaum et al. [2] reported that iron-deficiency anaemia, haemoglobinopathies and parasitic diseases were the most frequent causes of anaemia worldwide. …

Hayden SJ, Albert TJ, Watkins TR, Swenson ER (2012) Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med 185:1049–1057CrossRefPubMedPubMedCentral

Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, Flaxman SR, Pullan RL, Brooker SJ, Murray CJ (2014) A systematic analysis of global anemia burden from 1990 to 2010. Blood 123:615–624CrossRefPubMedPubMedCentral

Stauder R, Valer P, Theurl I (2018) Anemia at older age: etiologies, clinical implication, and management. Blood 131:505–514CrossRefPubMed

Ferrucci L, Guralnik JM, Bandinelli S, Semba RD, Lauretani F, Corsi A, Ruggerio C, Ershler WB, Longo DL (2007) Types of anaemia in older patients is characterised by low levels of erythropoietin and levels of pro-inflammatory markers. Br J Haematol 136:849–855CrossRefPubMedPubMedCentral

Ganz T, Nemeth E (2015) Iron homeostasis in host defence and inflammation. Nat Rev Immunol 15:500–510CrossRefPubMedPubMedCentral

Pagani A, Nai A, Corna G, Bosurgi L, Rovere-Querini P, Camaschella C, Silvestri L (2011) Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 118:736–746CrossRefPubMed

Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. NEJM 364:656–665CrossRefPubMed

Mohus RM, Paulsen J, Gustad L, Askim L, Askim A, Mehl A, DeWan AT, Afset JE, Asvold BO, Solligard E, Damas JK (2018) Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT Study in Norway. Intens Care Med 44:1276–1283CrossRef

Fonseca C, Marques F, Robalo Nunes A, Belo A et al (2016) Prevalence of anaemia and iron deficiency in Portugal: the EMPIRE study. Intern Med J 46:470–478CrossRefPubMed

10.

Vincent JL, Piagnerelli M (2006) Transfusion in the intensive care unit. Crit Care Med 34:S96–S101CrossRefPubMed

11.

Piagnerelli M, Cotton F, Herpain A, Rapotec A, Chatti R, Gulbis B, Vincent JL (2013) Time course of iron metabolism in critically ill patients. Acta Clin Belg 68:22–27CrossRefPubMed

12.

Boshuizen M, Binnekade JM, Nota B, van de Groen K, Cremer OL, Tuinman PR, Horn J, van Bruggen R, Juffermans NP, Molecular Diagnosis and Risk Stratification of Sepsis (MARS) Consortium (2018) Iron metabolism in critically ill patients developing anemia of inflammation: a case control study. Ann Intens Care 8:56CrossRef

13.

Stefanova D, Raychev A, Deville J, Humphries R, Campeau S, Ruchala P, Nemeth E, Ganz T, Bulut Y (2018) Hepcidin protects against lethal Escherichia coli sepsis in mice inoculated with isolates from septic patients. Infect Immun 86:e00253-18CrossRefPubMed

14.

Stefanova D, Raychev A, Arezes J, Ruchala P, Gabayan V, Skurnik M, Dillon BJ, Horwitz MA, Ganz T, Bulut Y, Nemeth E (2017) Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. Blood 130:245–257CrossRefPubMedPubMedCentral

15.

Theurl I, Schroll A, Sonnweber T, Nairz M, Theurl M, Willenbacher W, Eller K, Wolf D, Seifert M, Sun CC, Babitt JL, Hong CC, Menhall T, Gearing P, Lin HY, Weiss G (2011) Pharmacologic inhibition of hepcidin expression reverse anemia of chronic inflammation in rats. Blood 118:4977–4984CrossRefPubMedPubMedCentral

16.

IRONMAN Investigators, Litton E, Baker S, Erber WN, Farmer S, Ferrier J, French C, Gummer J, Hawkins D, Higgins A, Hofmann A, De Keulenaer B, McMorrow J, Olynyk JK, Richards T, Towler S, Trengove R, Webb S, Australian and New Zealand Intensive Care Society Clinical Trials Group (2016) Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicenter randomized blind trial: a randomized trial of IV iron in critical illness. Intens Care Med 42:1715–1722CrossRef

17.

Pierraci FM, Stovall RT, Jaouen B, Rodil M, Cappa A, Burlew CC, Holena DN, Maier R, Berry S, Jurkovich J, Moore EE (2014) A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness. Crit Care Med 42:2048–2057CrossRef

Title: Iron deficiency and infection: another pathway to explore in critically ill patients?
Authors: Erik R. Swenson
Raphaël Porcher
Michaël Piagnerelli
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 12/2018
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-018-5438-8

At a glance: The STEP trials

Springer Medicine

Iron deficiency and infection: another pathway to explore in critically ill patients?

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2018

Steroids and severe pneumonia. Ready for the winter? Discussion on “Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study”

Have we averted deaths using venoarterial ECMO?

New molecular semi-quantification tool provides reliable microbiological evidence for pulmonary infection

Gulliver’s travels in the intensive care unit

Uncommon barotrauma while on high-flow nasal cannula

Cutaneous infection with Mycobacterium abscessus